MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF Read more about MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF France13753475.6Filed on 2015-02-20
MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF Read more about MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF Germany13753475.6Filed on 2015-02-20
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Patent Cooperation TreatyPCT/US2017/60304Filed on 2017-11-07
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Portugal13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use The Netherlands13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Liechtenstein13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Italy13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Ireland13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use United Kingdom13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use France13720737.9Filed on 2014-11-26